"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 10 | 10 |
| 1998 | 0 | 12 | 12 |
| 1999 | 0 | 11 | 11 |
| 2000 | 0 | 6 | 6 |
| 2001 | 0 | 6 | 6 |
| 2002 | 0 | 12 | 12 |
| 2003 | 0 | 10 | 10 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 8 | 8 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 12 | 12 |
| 2009 | 0 | 13 | 13 |
| 2010 | 0 | 17 | 17 |
| 2011 | 0 | 21 | 21 |
| 2012 | 0 | 19 | 19 |
| 2013 | 0 | 12 | 12 |
| 2014 | 1 | 15 | 16 |
| 2015 | 0 | 21 | 21 |
| 2016 | 0 | 22 | 22 |
| 2017 | 0 | 15 | 15 |
| 2018 | 0 | 33 | 33 |
| 2019 | 0 | 24 | 24 |
| 2020 | 0 | 31 | 31 |
| 2021 | 0 | 28 | 28 |
| 2022 | 0 | 12 | 12 |
| 2023 | 0 | 11 | 11 |
| 2024 | 0 | 20 | 20 |
| 2025 | 0 | 17 | 17 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward. Expert Rev Gastroenterol Hepatol. 2026 Mar; 20(3):233-246.
-
Oral ?-Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point-Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones. Pharmacotherapy. 2026 Mar; 46(3):e70118.
-
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention. Diabetes Care. 2026 Feb 01; 49(2):344-351.
-
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial. JAMA. 2026 01 13; 335(2):129-139.
-
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk. J Infect Dis. 2025 Dec 20; 232(6):1446-1456.
-
Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in Black women of low socioeconomic status. Support Care Cancer. 2025 Dec 11; 34(1):24.
-
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial. JAMA. 2025 11 25; 334(20):1816-1826.
-
Identification of factors associated with non-adherence to oral endocrine therapy in breast cancer patients of low socioeconomic status: a single centre retrospective study. Int J Clin Pharm. 2026 Feb; 48(1):266-273.
-
Standardizing oral food challenge protocols in food protein-induced enterocolitis syndrome (FPIES): A call for consensus. Ann Allergy Asthma Immunol. 2026 Jan; 136(1):16-24.
-
Decreased risk of cardiovascular disease in dermatology patients taking niacinamide: A TriNetX cohort study. J Am Acad Dermatol. 2026 Mar; 94(3):828-834.